GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biocon Ltd (BOM:532523) » Definitions » Marketable Securities

Biocon (BOM:532523) Marketable Securities : ₹16,975 Mil (As of Mar. 2025)


View and export this data going back to 2004. Start your Free Trial

What is Biocon Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Biocon's Marketable Securities for the quarter that ended in Mar. 2025 was ₹16,975 Mil.

Biocon's annual Marketable Securities declined from Mar. 2023 (₹24,028 Mil) to Mar. 2024 (₹18,784 Mil) and declined from Mar. 2024 (₹18,784 Mil) to Mar. 2025 (₹16,975 Mil).


Biocon Marketable Securities Historical Data

The historical data trend for Biocon's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biocon Marketable Securities Chart

Biocon Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,857.00 13,360.00 24,028.00 18,784.00 16,975.00

Biocon Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18,784.00 - 14,295.00 - 16,975.00

Biocon Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Biocon  (BOM:532523) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


Biocon Marketable Securities Related Terms

Thank you for viewing the detailed overview of Biocon's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Biocon Business Description

Traded in Other Exchanges
Address
20th KM, Hosur Road, Electronics City, Bengaluru, KA, IND, 560100
Biocon Ltd is a biopharmaceutical company that develops biotechnology therapies for diseases. The company is focused on developing, manufacturing, and supplying novel and biosimilar pharmaceuticals for diabetes, cancer, and autoimmune conditions. Biocon has four reportable segments: Biosimilars which derives maximum revenue, Generics, Novel Biologics (Novels), and Research services (Research). The company provides integrated contract research and manufacturing services to pharmaceutical and biotechnology companies through its subsidiary Syngene. Geographically, the company generates a majority of its revenue from its customers located in India and the rest from Brazil, Singapore, and the rest of the world.

Biocon Headlines

No Headlines